KAREN PERRIN: Open Payments
NPI 1093750838 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$992 in 9 payments from 7 companies in 2025. Trend: 2023 $406 · 2024 $426 · 2025 $992
Food & beverage: $897Education: $95
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 2 | $232 |
| E.R. Squibb & Sons, L.L.C. | 2 | $216 |
| Sumitomo Pharma America, Inc. | 1 | $119 |
| PFIZER INC. | 1 | $118 |
| ABBVIE INC. | 1 | $114 |
| Genmab U.S., Inc. | 1 | $98 |
| SEAGEN INC. | 1 | $95 |
Products named: RYBREVANT, ORGOVYX, OPDIVO, TALZENNA, VENCLEXTA, Epkinly, REBLOZYL.
Industry payments across FL — which companies pay providers there.
